Investor''s Presentation based on Financial Results for the Half Year and the Financial Year ended 31st March 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Chemkart India reported FY26 consolidated revenue of Rs 21,483 lakhs, up 5.7% YoY, supported by 7.1% volume growth despite challenging global conditions including supply chain disruptions and pricing corrections. However, profitability declined significantly with EBITDA falling 14.3% to Rs 2,818 lakhs and PAT down 19.9% to Rs 1,966 lakhs. EBITDA margin compressed to 13.1% from 16.2% in FY25, and PAT margin fell to 9.1% from 12.1%. Management cited US tariff uncertainties and export headwinds as key challenges. The company maintains strong order visibility with Rs 6,526+ lakhs in advance and open orders. Construction of the EZRM SEZ manufacturing facility at JNPT is progressing with civil and structural works underway, marking the company's strategic entry into CDMO manufacturing.
The margin compression despite revenue growth signals operational challenges from input cost pressures and pricing environment. The strong order pipeline provides near-term revenue visibility, but shareholders should monitor the progress of the SEZ facility as a key driver for future margin improvement and manufacturing integration.